Herwig P. Moll

1.3k citations
32 papers · 633 indexed · h-index 14
Topics
Cytokine Signaling Pathways and Interactions (8 papers)interferon and immune responses (7 papers)NF-κB Signaling Pathways (7 papers)

In The Last Decade

Herwig P. Moll

31 papers receiving 631 citations

Peers

Herwig P. Moll
Comparison fields: 5 of 73
  • Molecular Biology 323
  • Oncology 200
  • Immunology 180
  • Cancer Research 129
  • Pulmonary and Respiratory Medicine 97
Replace Priya D. Issuree with:
Priya D. Issuree United States
Yvonne Vercoulen Netherlands
Dehong Yan China
Adnan K. Mookhtiar United States
Clara Redondo Spain
Kattria van der Ploeg United States
Lihui Qian China
Kotohiko Kimura Japan
Jinmei Yu China
Herwig P. Moll relative to Priya D. Issuree United States Priya D. Issuree's profile →
Citations per field
00.5×3.0×
Priya D. Issuree · 1×
Citations per year

Countries citing papers authored by Herwig P. Moll

Since Specialization
Citations

This map shows the geographic impact of Herwig P. Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herwig P. Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herwig P. Moll more than expected).

Fields of papers citing papers by Herwig P. Moll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herwig P. Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herwig P. Moll. The network helps show where Herwig P. Moll may publish in the future.

Co-authorship network of co-authors of Herwig P. Moll

This figure shows the co-authorship network connecting the top 25 collaborators of Herwig P. Moll. A scholar is included among the top collaborators of Herwig P. Moll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herwig P. Moll. Herwig P. Moll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 6
4 16
5 3
6 9
7 13
8 5
9 7
10 37
11 4
12 20
13 50
14 7
15 5
16 25
17 49
18 57
19 2
20 14

About Herwig P. Moll

Herwig P. Moll is a scholar working on Immunology, Cancer Research and Immunology and Allergy, having authored 32 papers that have together received 633 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), interferon and immune responses (7 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Cancer Research (129 citations), Immunology (180 citations) and Oncology (200 citations). Herwig P. Moll has collaborated with scholars based in Austria, United States and Hungary. Frequent co-authors include Emilio Casanova, Iris Z. Uras, Christiane Ferran, Christine Brostjan, Eva Csizmadia, Thomas Lavoie, Thomas Maier, Renata Padilha Guedes, Averil Ma and Andy Lee. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026